<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
</head>
<body style="word-wrap: break-word; -webkit-nbsp-mode: space; -webkit-line-break: after-white-space;">
<div>
<div>
<div style="font-family: Calibri, sans-serif; color: rgb(0, 0, 0); font-size: 14px;">
Hi all,</div>
<div style="font-family: Calibri, sans-serif; color: rgb(0, 0, 0); font-size: 14px;">
<br>
</div>
<div><font face="Calibri,sans-serif">Our next MOS seminar will be held next Tuesday, November 22 at 12pm in the Grier Room (34-401):</font></div>
<div><font face="Calibri,sans-serif"><br>
</font></div>
<div><font face="Calibri,sans-serif">Prof. Vadim Backman of Northwestern University will be speaking on
<b>"Label-free nanoscale optical imaging: uncovering a new biological code,”</b> with abstract to come. </font></div>
<div><font face="Calibri,sans-serif"><br>
</font></div>
<div><span style="text-align: justify;"><i>Dr. Vadim Backman is the Walter Dill Scott Professor of Biomedical Engineering at the McCormick School of Engineering and Applied Sciences, Northwestern University and Program Leader in Cancer and Physical Sciences
at the Robert H. Lurie Comprehensive Cancer Center. He received his Ph.D. in Medical Engineering from Harvard University and the Massachusetts Institute of Technology. Dr. Backman’s research is focused on bridging advances in biophotonics into biomedical
research and clinical medicine. He develops novel optics technologies for characterization and imaging of biological tissue with a focus on the nanoscale and molecular levels. His research spans from cancer biophysics to novel optical diagnostic and imaging
techniques to multi-center clinical trials. Dr. Backman has received numerous awards including being selected as one of the top 100 young innovators in the world by MIT Technology Review Magazine, and has served on multiple NIH and NSF review panels, as well
as chair of various scientific conferences such as OSA Biomed and SPIE Biomedical Applications of Light Scattering. He has published more than 200 papers in peer-reviewed journals including Nature, Nature Medicine, PNAS, and Physical Review Letters, and holds
over 20 patents. In the past three years, he has served as the principle investigator on more than 20 grants from the National Institutes of Health and National Science Foundation, including an NIH Bioengineering Research Partnership. At Northwestern, he
teaches advanced classes in optics and human physiology. Dr. Backman is the co-founder of two biotech companies.</i></span></div>
<div style="font-family: Calibri, sans-serif; color: rgb(0, 0, 0); font-size: 14px;">
<br>
</div>
<div style="font-family: Calibri, sans-serif; color: rgb(0, 0, 0); font-size: 14px;">
Lunch will be served at 1pm, immediately following the seminar.</div>
<div style="font-family: Calibri, sans-serif; color: rgb(0, 0, 0); font-size: 14px;">
<br>
</div>
<div style="font-family: Calibri, sans-serif; color: rgb(0, 0, 0); font-size: 14px;">
<div id="MAC_OUTLOOK_SIGNATURE">
<div><b style="font-family: Tahoma;">Christine Brooks</b></div>
<div>Administrative Assistant</div>
<div>Massachusetts Institute of Technology</div>
<div>Department of Chemistry</div>
<div>77 Massachusetts Ave, 6-333</div>
<div>Cambridge, MA 02139</div>
<div>p: 617.253.7239</div>
<div>e: cbrooks@mit.edu</div>
<div><br>
</div>
</div>
</div>
</div>
</div>
</body>
</html>